RTX
RTX Corporation
$196.21
$0.00(0.00%)
61
Overall
90
Value
27
Tech
68
Quality
Market Cap
$211.42B
Volume
4.11M
52W Range
$112.27 - $214.50
Target Price
$215.43
Company Overview
| Mkt Cap | $211.42B | Price | $196.21 |
| Volume | 4.11M | Change | +0.00% |
| P/E Ratio | 44.3 | Open | $195.08 |
| Revenue | $80.7B | Prev Close | $196.21 |
| Net Income | $4.8B | 52W Range | $112.27 - $214.50 |
| Div Yield | 2.72% | Target | $215.43 |
| Overall | 61 | Value | 90 |
| Quality | 68 | Technical | 27 |
No chart data available
Latest News
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Green Thumb Industries (OtherGTBIF)
Christine Brown•2 days ago
Anthropic Finalizes $400 Million Takeover of AI Startup Coefficient Bio
Joy Iyke•2 days ago
Galera Sets Deadlines for 2026 Combined Annual Meeting
TipRanks Auto-Generated Newsdesk•2 days ago
XORTX Therapeutics Secures Exchange Approvals for 1-for-5 Share Consolidation Effective April 6
TipRanks Auto-Generated Newsdesk•4 days ago
Vertex Advances FDA Filing for IgA Nephropathy Therapy
TipRanks Auto-Generated Newsdesk•5 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RTX | $196.21 | 0% | 4.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |